Top

Ebola Vaccine Prototype Manufacture

Active

W15QKN-19-Z-044XFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The announcement serves as an advanced notification from the Department of Defense regarding the anticipated Request for Prototype Proposals (RPP 19-02) focused on the development and manufacture of an Ebola vaccine prototype under the Medical Countermeasure Systems Research and Development program. This is not a solicitation for proposals or an award announcement but rather informs members of the Medical CBRN Defense Consortium (MCDC) and industry stakeholders of the government's intent to execute project awards through an Other Transaction Agreement (OTA) mechanism. The government previously established an OTA with the MCDC on April 8, 2016, to support prototype projects related to medical countermeasures, and expects that awardees of the upcoming RPP will be chosen from consortium members submitting proposals. The anticipated project calls for white papers and full proposals for the Ebola Vaccine Prototype Manufacture under solicitation number W15QKN-19-Z-044X, classified under NAICS code 541990. Awards resulting from this prototype effort may lead to follow-on production contracts without further competitive procedures, contingent upon successful completion of the prototype phase, in accordance with 10 U.S.C. 2371b(f). The contracting office is located at Picatinny Arsenal, New Jersey, with points of contact available to provide further information. The overall intent is to streamline development of critical medical countermeasures while enabling a quicker transition to production if the prototype demonstrates success.

General Info

Department of Defense to request Ebola vaccine prototype proposals via OTA with MCDC consortium.

Agency

Department Of Defense → W6QK Acc-Pica

NAICS

541990 - All Other Professional, Scientific, and Technical Services

Place of Performance

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedOct 11

special-notice

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Defense → W6QK Acc-Pica

Contacts1 person available

OfficePICATINNY ARSENAL, NJ, 07806-5000, USA

Organization / AgencyDepartment Of Defense → W6QK Acc-Pica

Office AddressPICATINNY ARSENAL, NJ, 07806-5000, USA

Contacts

Vincent Samuel ConcaContract Specialist

contact@example.gov

Full Description

This is not a Request for Prototype Proposals, but for planning purposes only. A project award will not be awarded from this announcement. The Government intends to announce one Request for Prototype Proposals (RPP 19-02) for execution of a project award(s) in support of Medical Countermeasure Systems Research and Development related to specified project requirements. The purpose of this announcement is to provide members of the Medical CBRN Defense Consortium, and industry in general, advanced notification of Government intent. On 08 April 2016, the Government entered into an Other Transaction Agreement (OTA) with one (1) consortium, the Medical CBRN Defense Consortium (MCDC), in support of Medical Countermeasure Systems related research and development prototype projects. It is the intent of the Government to make project award(s) to member(s) of the MCDC as a result of member project proposals submitted via the Request for Prototype Proposals process. RPP 19-02 The Government anticipates one (1) project for white papers and full proposals to be solicited via W15QKN-16-9-1002 - consisting of the following: 1. Ebola Vaccine Prototype Manufacture. Please note that any Prototype Other Transaction Agreement awarded in response to the anticipated RPP (solicitation) will include the following statement relative to the potential for follow-on production: "In accordance with 10.U.S.C. 2371b(f), and upon a determination that the prototype project for this transaction has been successfully completed, this competitively awarded prototype OTA may result in the award of a follow-on production contract or transaction without the use of competitive procedures."